Enlivex Therapeutics

+$0.06 (+0.64%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ENLV and other stocks, options, and ETFs commission-free!

About ENLV

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn's disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders.

CEO
Oren Hershkovitz
Employees
50
Headquarters
Nes-Ziona, Tel Aviv
Founded
2012

ENLV Key Statistics

Market Cap
165.54M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.27K
High Today
$9.53
Low Today
$9.27
Open Price
$9.30
Volume
20.64K
52 Week High
$29.40
52 Week Low
$4.49

ENLV Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q1 FY16
Q2 FY16
Q3 FY16
Q4 FY16
Q1 FY17
Q2 FY17
Q3 FY17
Q4 FY17
Estimated
— per share
Actual
-$0.16 per share

You May Also Like

HWC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure